05:53 PM EDT, 06/04/2024 (MT Newswires) -- Zevra Therapeutics ( ZVRA ) filed a shelf registration statement with the US Securities and Exchange Commission Tuesday covering the potential sale of up to $350 million of its securities from time to time in one or more offerings.

The statement covers the company's common and preferred shares, debt securities and warrants, according to a regulatory filing.

The company's shares were down 4.3% in after-hours activity.

Price: 4.5000, Change: -0.20, Percent Change: -4.26